Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway
Laura Adesso(Sapienza University of Rome), Claudio Sette(University of Rome Tor Vergata)
Cited by 132
Related Papers
Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells
|Oncogene|2015|283
Alternative splicing and cell survival: from tissue homeostasis to disease
|Cell Death and Differentiation|2016|173
Tr‐kit‐induced resumption of the cell cycle in mouse eggs requires activation of a Src‐like kinase
|The EMBO Journal|2002|137
Sam68 regulates translation of target mRNAs in male germ cells, necessary for mouse spermatogenesis
|The Journal of Cell Biology|2009|136